Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Treatments for HBV: A Glimpse into the Future. | Viruses | 2021 | 34578347 | PubTator, text mining | PubMed |
| Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy. | Viruses | 2021 | 34578273 | PubTator, text mining | PubMed |
| Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation. | Molecules | 2021 | 34576971 | PubTator, text mining | PubMed |
| HBV and HDV: New Treatments on the Horizon. | J Clin Med | 2021 | 34575165 | PubTator, text mining | PubMed |
| Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks. | Cells | 2021 | 34571970 | PubTator, text mining | PubMed |
| Current Models for Predicting Drug-induced Cholestasis: The Role of Hepatobiliary Transport System. | Iran J Pharm Res | 2021 | 34567142 | PubTator, text mining | PubMed |
| Vitamin D signaling inhibits HBV activity by directly targeting the HBV core promoter. | J Biol Chem | 2021 | 34562448 | PubTator, text mining | PubMed |
| Review article: therapeutic aspects of bile acid signalling in the gut-liver axis. | Aliment Pharmacol Ther | 2021 | 34555862 | PubTator, text mining | PubMed |
| Evaluation of the hepatotoxicity of the novel GPR40 (FFAR1) agonist CPL207280 in the rat and monkey. | PLoS One | 2021 | 34555055 | PubTator, text mining | PubMed |
| Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development. | Front Endocrinol (Lausanne) | 2021 | 34539576 | PubTator, text mining | PubMed |
| A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery. | Nat Commun | 2021 | 34535664 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection. | Sci Rep | 2021 | 34526634 | PubTator, text mining | PubMed |
| Defending Antiviral Cationic Amphiphilic Drugs That May Cause Drug-Induced Phospholipidosis. | J Chem Inf Model | 2021 | 34516123 | PubTator, text mining | PubMed |
| Editorial: Viral Hepatitis: Pathophysiology, Prevention, and Control. | Front Cell Infect Microbiol | 2021 | 34513722 | PubTator, text mining | PubMed |
| Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | 34503196 | PubTator, text mining | PubMed |
| Odevixibat: First Approval. | Drugs | 2021 | 34499340 | PubTator, text mining | PubMed |
| Predicting the effect of indirect cell kill in the treatment of multiple brain metastases via single-isocenter/multitarget volumetric modulated arc therapy stereotactic radiosurgery. | J Appl Clin Med Phys | 2021 | 34498359 | PubTator, text mining | PubMed |
| Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics. | Sci Rep | 2021 | 34497279 | PubTator, text mining | PubMed |
| Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics. | Adv Sci (Weinh) | 2021 | 34494387 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=55